Trikafta
N-(2,4-ditert-butyl-5-hydroxyphenyl)-4-oxo-1H-quinoline-3-carboxamide;bis(1-(2,2-difluoro-1,3-benzodioxol-5-yl)-N-[1-[(2R)-2,3-dihydroxypropyl]-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)indol-5-yl]cyclopropane-1-carboxamide)
Molecular Identity
Trikafta
N-(2,4-ditert-butyl-5-hydroxyphenyl)-4-oxo-1H-quinoline-3-carboxamide;bis(1-(2,2-difluoro-1,3-benzodioxol-5-yl)-N-[1-[(2R)-2,3-dihydroxypropyl]-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)indol-5-yl]cyclopropane-1-carboxamide)
PubChem CID: 165363555
2D Structure
Properties
C76H82F6N6O15
Molecular Formula
1433.50
Molecular Weight
g/mol
1432.5742
Exact Mass
Da
305
TPSA
May have limited oral absorption
11
H-Bond Donors
22
H-Bond Acceptors
1530
Complexity
SMILES
Canonical SMILES
SMILES: Synonyms(5)
TrikaftaDTXSID6010279082398469-65-1RefChem:933430DTXCID201513460
Data from PubChem (NCBI)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Drug Network
Trials and conditions connected to Trikafta
Loading drug network...